Primary Site >> Biliary tract Cancer
Gene >> CDAN1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. PMID: 12504047 Ref: Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. PMID: 12932661 |
Ref: Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. PMID: 16786333 |
Ref: A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors. PMID: 18172649 |
Ref: Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004). PMID: 24614947 Ref: Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization. PMID: 24661655 |
Ref: Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer. PMID: 25422155 Ref: Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer. PMID: 25877225 |
Ref: Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer. PMID: 29995287 |